Price loading...

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
19 June 2013
Listed Since
23 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia

£325.00 12 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 08 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe

£325.00 24 Feb 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
97% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan

£495.00 15 Feb 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China
97% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China

£495.00 12 Jan 2026
The 2013-2018 Outlook for Scale Inhibitors in India
96% match

The 2013-2018 Outlook for Scale Inhibitors in India

£495.00 09 Jan 2026
The 2013-2018 Outlook for Drugs in India
96% match

The 2013-2018 Outlook for Drugs in India

£495.00 16 Dec 2025
The 2013-2018 Outlook for Systemic Antiviral Pharmaceuticals in India
96% match

The 2013-2018 Outlook for Systemic Antiviral Pharmaceuticals in India

£495.00 11 Jan 2026
The 2013-2018 Outlook for Bisphosphonates in India
96% match

The 2013-2018 Outlook for Bisphosphonates in India

£495.00 07 Jan 2026
The 2013-2018 Outlook for Peripheral Vasodilator Pharmaceuticals in India
96% match

The 2013-2018 Outlook for Peripheral Vasodilator Pharmaceuticals in India

£495.00 08 Jan 2026
The 2013-2018 Outlook for Antibacterial Drugs in India
96% match

The 2013-2018 Outlook for Antibacterial Drugs in India

£495.00 12 Jan 2026
The 2013-2018 Outlook for Digestion Aids in India
96% match

The 2013-2018 Outlook for Digestion Aids in India

£495.00 12 Jan 2026
The 2013-2018 Outlook for Erythropoietins in India
95% match

The 2013-2018 Outlook for Erythropoietins in India

£495.00 13 Jan 2026
The 2013-2018 Outlook for Over-The-Counter Generic Drugs in India
95% match

The 2013-2018 Outlook for Over-The-Counter Generic Drugs in India

£495.00 11 Jan 2026
The 2013-2018 Outlook for Pipettes and Pipettors in India
95% match

The 2013-2018 Outlook for Pipettes and Pipettors in India

£495.00 12 Jan 2026
The 2013-2018 Outlook for Generic Drugs in India
95% match

The 2013-2018 Outlook for Generic Drugs in India

£495.00 13 Apr 2026
The 2013-2018 Outlook for Coronary Vasodilator Pharmaceuticals in India
95% match

The 2013-2018 Outlook for Coronary Vasodilator Pharmaceuticals in India

£495.00 06 Jan 2026
The 2013-2018 Outlook for Topical Antiseptic Medications in India
95% match

The 2013-2018 Outlook for Topical Antiseptic Medications in India

£495.00 05 Mar 2026
The 2013-2018 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in India
95% match

The 2013-2018 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in India

£495.00 11 Jan 2026
The 2013-2018 Outlook for Propionic Acid in India
95% match

The 2013-2018 Outlook for Propionic Acid in India

£495.00 16 Dec 2025
The 2013-2018 Outlook for Industrial Enzymes in India
95% match

The 2013-2018 Outlook for Industrial Enzymes in India

£495.00 09 Jan 2026
The 2013-2018 Outlook for Lou Gehrig's Disease Drugs in India
95% match

The 2013-2018 Outlook for Lou Gehrig's Disease Drugs in India

£495.00 28 Jan 2026
The 2013-2018 Outlook for Human Growth Hormone Drugs in India
95% match

The 2013-2018 Outlook for Human Growth Hormone Drugs in India

£495.00 14 Jan 2026
The 2013-2018 Outlook for Anti-Hypertensive Drugs in India
95% match

The 2013-2018 Outlook for Anti-Hypertensive Drugs in India

£495.00 11 Jan 2026